首页 > 最新文献

Plastic and reconstructive surgery最新文献

英文 中文
Neuropathic Pain after Major Limb Amputation: A Cross-Sectional Study. 大肢截肢后的神经性疼痛:一项横断面研究。
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-06-04 DOI: 10.1097/PRS.0000000000011568
Mirte Langeveld, Floris V Raasveld, Caroline A Hundepool, Tjebbe Hagenaars, Dorien C M Spijkerman, Kyle R Eberlin, J Michiel Zuidam

Background: Residual limb pain (RLP) and phantom pain can arise following amputation and may require additional treatment or surgery. This study aimed to determine the prevalence of neuropathic RLP following limb amputation and identify prognostic factors for the development of neuropathic RLP.

Methods: A cross-sectional study was performed of patients who underwent upper or lower extremity amputation between 1990 and 2021 with a minimum of 12 months' follow-up. The primary outcome was the prevalence of neuropathic RLP, defined as a 0 to 10 numeric rating analog scale pain score in the residual limb of greater than or equal to 4, in combination with a score greater than or equal to 4 on the short-form Douleur Neuropathic 4 questionnaire, validated for discriminating between nociceptive and neuropathic pain. The secondary outcome was quality of life for amputation patients with and without (neuropathic) RLP. A multivariable linear regression model was used to identify prognostic factors for neuropathic RLP development.

Results: A total of 121 patients were included: 87 with lower extremity amputations, 29 with upper extremity amputations, and 5 with both. Neuropathic RLP was experienced by 21.5%, whereas 10.7% reported nonneuropathic RLP. Smoking status and complex regional pain syndrome as indications for limb amputation were associated with more severe neuropathic pain symptoms. Patients experiencing neuropathic RLP reported a significantly lower quality of life compared with patients without neuropathic RLP.

Conclusions: This study demonstrates that neuropathic RLP is common after limb amputation and impacts daily functioning. The absence of numerous manageable prognostic factors associated with neuropathic pain development emphasizes the importance of the consideration of prophylactic interventions at the time of amputation.

Clinical question/level of evidence: Risk, III.

背景目标:截肢后会出现残肢痛(RLP)和幻痛,可能需要额外的治疗或手术。本研究旨在确定截肢后神经病理性残肢痛的发病率,并找出神经病理性残肢痛的预后因素:该研究对1990年至2021年间接受上肢或下肢截肢手术、随访至少12个月的患者进行了横断面研究。主要结果是神经性 RLP 的患病率,其定义是残肢 0-10 NRS 疼痛评分≥4 分,同时短式 DN4 问卷(s-DN4)评分≥4 分,该问卷经验证可区分痛觉性疼痛和神经性疼痛。次要结果是有和没有(神经性)RLP的截肢者的生活质量。采用多变量线性回归模型确定神经性 RLP 发生的预后因素:结果:共纳入 121 名患者:结果:共纳入121名患者:87名下肢截肢患者,29名上肢截肢患者,5名上肢和下肢均截肢患者。21.5%的患者出现神经性 RLP,10.7%的患者出现非神经性 RLP。吸烟状况和复杂性区域疼痛综合症作为截肢指征与更严重的神经性疼痛症状有关。与不伴有神经病理性疼痛的患者相比,伴有神经病理性疼痛的患者的生活质量明显较低:本研究表明,神经性 RLP 在截肢后很常见,并影响日常功能。由于缺乏与神经性疼痛发展相关的多种可控预后因素,因此强调了在截肢时考虑预防性干预措施的重要性。
{"title":"Neuropathic Pain after Major Limb Amputation: A Cross-Sectional Study.","authors":"Mirte Langeveld, Floris V Raasveld, Caroline A Hundepool, Tjebbe Hagenaars, Dorien C M Spijkerman, Kyle R Eberlin, J Michiel Zuidam","doi":"10.1097/PRS.0000000000011568","DOIUrl":"10.1097/PRS.0000000000011568","url":null,"abstract":"<p><strong>Background: </strong>Residual limb pain (RLP) and phantom pain can arise following amputation and may require additional treatment or surgery. This study aimed to determine the prevalence of neuropathic RLP following limb amputation and identify prognostic factors for the development of neuropathic RLP.</p><p><strong>Methods: </strong>A cross-sectional study was performed of patients who underwent upper or lower extremity amputation between 1990 and 2021 with a minimum of 12 months' follow-up. The primary outcome was the prevalence of neuropathic RLP, defined as a 0 to 10 numeric rating analog scale pain score in the residual limb of greater than or equal to 4, in combination with a score greater than or equal to 4 on the short-form Douleur Neuropathic 4 questionnaire, validated for discriminating between nociceptive and neuropathic pain. The secondary outcome was quality of life for amputation patients with and without (neuropathic) RLP. A multivariable linear regression model was used to identify prognostic factors for neuropathic RLP development.</p><p><strong>Results: </strong>A total of 121 patients were included: 87 with lower extremity amputations, 29 with upper extremity amputations, and 5 with both. Neuropathic RLP was experienced by 21.5%, whereas 10.7% reported nonneuropathic RLP. Smoking status and complex regional pain syndrome as indications for limb amputation were associated with more severe neuropathic pain symptoms. Patients experiencing neuropathic RLP reported a significantly lower quality of life compared with patients without neuropathic RLP.</p><p><strong>Conclusions: </strong>This study demonstrates that neuropathic RLP is common after limb amputation and impacts daily functioning. The absence of numerous manageable prognostic factors associated with neuropathic pain development emphasizes the importance of the consideration of prophylactic interventions at the time of amputation.</p><p><strong>Clinical question/level of evidence: </strong>Risk, III.</p>","PeriodicalId":20128,"journal":{"name":"Plastic and reconstructive surgery","volume":" ","pages":"419e-427e"},"PeriodicalIF":3.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141301339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Explantation with Lateral Pedicle Mastopexy. 侧椎体乳突切除术
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-07-19 DOI: 10.1097/PRS.0000000000011645
R Douglas Macmillan, Kara Bell, Emma Wilson, Kristjan S Asgeirsson

Background: Although breast explantation combined with mastopexy is an increasingly common procedure, it does present certain technical difficulties. The authors present a technique of explantation mastopexy with the use of an extended lateral pedicle for autoaugmentation.

Methods: A consecutive series of 40 cases was reviewed retrospectively, with a patient-reported outcome questionnaire and photography at 3 and 12 months.

Results: The mean patient age was 57 years (range, 40 to 70 years), and the mean duration of implantation was 20.4 years (range, 7 to 42 years). Twelve women had undergone previous mastopexy (30%). Minor wound complications requiring simple dressings were seen in 7 patients (17.5%). Major infected wound problems occurred in 1 patient, who was a smoker and had other comorbidities. All except 1 patient reported being satisfied or very satisfied with the outcome, with a mean patient-reported satisfaction score of 4.9 of 5. When the photographs were independently assessed by a cosmetic practitioner, all patients were rated as average, good, or very good, with a mean score of 4.1 of 5.

Conclusions: The procedure is associated with low risk of postoperative complications, good cosmetic outcomes, and a high degree of patient satisfaction. The authors believe this technique provides a logical, reproducible method for combined explantation and mastopexy.

Clinical question/level of evidence: Therapeutic, IV.

背景:虽然乳房切除术结合乳房整形术是一种越来越常见的手术,但它确实存在一定的技术难度。我们介绍了一种使用扩展侧蒂进行自动增大的切除乳房整形术:方法:回顾性分析 40 例连续病例,包括患者报告结果问卷以及 3 个月和 12 个月的照片:平均年龄为 57 岁(40 - 70 岁不等),平均植入时间为 20.4 年(7 - 42 年不等)。12名女性曾接受过乳房整形手术(30%)。7例(17.5%)患者出现了需要简单包扎的轻微伤口并发症。1例患者出现了严重的伤口感染问题,该患者吸烟并患有其他并发症。除 1 例患者外,所有患者均对治疗结果表示满意或非常满意,平均满意度为 4.9/5。由美容医师对照片进行独立评估后,所有病例均被评为一般、好或非常好,平均得分为 4.1/5:该手术术后并发症风险低,美容效果好,患者满意度高。我们认为这项技术为联合切除乳房和乳房整形术提供了一种合理、可重复的方法。
{"title":"Explantation with Lateral Pedicle Mastopexy.","authors":"R Douglas Macmillan, Kara Bell, Emma Wilson, Kristjan S Asgeirsson","doi":"10.1097/PRS.0000000000011645","DOIUrl":"10.1097/PRS.0000000000011645","url":null,"abstract":"<p><strong>Background: </strong>Although breast explantation combined with mastopexy is an increasingly common procedure, it does present certain technical difficulties. The authors present a technique of explantation mastopexy with the use of an extended lateral pedicle for autoaugmentation.</p><p><strong>Methods: </strong>A consecutive series of 40 cases was reviewed retrospectively, with a patient-reported outcome questionnaire and photography at 3 and 12 months.</p><p><strong>Results: </strong>The mean patient age was 57 years (range, 40 to 70 years), and the mean duration of implantation was 20.4 years (range, 7 to 42 years). Twelve women had undergone previous mastopexy (30%). Minor wound complications requiring simple dressings were seen in 7 patients (17.5%). Major infected wound problems occurred in 1 patient, who was a smoker and had other comorbidities. All except 1 patient reported being satisfied or very satisfied with the outcome, with a mean patient-reported satisfaction score of 4.9 of 5. When the photographs were independently assessed by a cosmetic practitioner, all patients were rated as average, good, or very good, with a mean score of 4.1 of 5.</p><p><strong>Conclusions: </strong>The procedure is associated with low risk of postoperative complications, good cosmetic outcomes, and a high degree of patient satisfaction. The authors believe this technique provides a logical, reproducible method for combined explantation and mastopexy.</p><p><strong>Clinical question/level of evidence: </strong>Therapeutic, IV.</p>","PeriodicalId":20128,"journal":{"name":"Plastic and reconstructive surgery","volume":" ","pages":"269-278"},"PeriodicalIF":3.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141724165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimal Strategies for Autologous Fat Grafting in Breast Augmentation and Reconstruction: A Systematic Review and Network Meta-Analysis.
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-07-19 DOI: 10.1097/PRS.0000000000011653
Yulin Sun, Qian Liu, Jie Zhu, Hao Hu, Lu Lu, Jianghui Ying, Rong Guo, Xiuyu Ye, Lie Zhu, Hua Jiang

Background: Cell-assisted lipotransfer (CAL) and platelet-rich plasma (PRP)-assisted lipotransfer have been used to overcome the low survival rate of conventional lipotransfer. However, there is still insufficient evidence to determine which technique is the best strategy for autologous fat grafting in breast cosmetic and reconstructive surgery. The present study aimed to compare the efficacy of traditional fat transplantation, CAL, and PRP-assisted lipotransfer.

Methods: A systematic search was conducted in several databases, including PubMed, Web of Science, Cochrane, ClinicalTrials.gov, and Embase, concluding on January 21, 2024, to identify studies that met the inclusion criteria. Twelve studies were included after a rigorous selection process based on predefined criteria. Statistical analyses were conducted using R version 4.0.5 software with the netmeta and dmetar packages, utilizing a frequentist approach with a random-effects model. A network meta-analysis was performed to compare different fat graft procedures with regard to fat survival rate and complication events.

Results: CAL and PRP-assisted lipotransfer were better than traditional fat grafting in terms of fat survival rate. In addition, there was no significant difference in the incidence of postoperative complications among the CAL, PRP, and traditional groups.

Conclusions: Given the results of network meta-analysis, it appears that both CAL and PRP-assisted lipotransfer have a higher fat survival rate for autologous fat grafting in breast augmentation and reconstruction. However, the transplantation strategy still needs to be analyzed based on actual conditions in clinical applications.

{"title":"Optimal Strategies for Autologous Fat Grafting in Breast Augmentation and Reconstruction: A Systematic Review and Network Meta-Analysis.","authors":"Yulin Sun, Qian Liu, Jie Zhu, Hao Hu, Lu Lu, Jianghui Ying, Rong Guo, Xiuyu Ye, Lie Zhu, Hua Jiang","doi":"10.1097/PRS.0000000000011653","DOIUrl":"https://doi.org/10.1097/PRS.0000000000011653","url":null,"abstract":"<p><strong>Background: </strong>Cell-assisted lipotransfer (CAL) and platelet-rich plasma (PRP)-assisted lipotransfer have been used to overcome the low survival rate of conventional lipotransfer. However, there is still insufficient evidence to determine which technique is the best strategy for autologous fat grafting in breast cosmetic and reconstructive surgery. The present study aimed to compare the efficacy of traditional fat transplantation, CAL, and PRP-assisted lipotransfer.</p><p><strong>Methods: </strong>A systematic search was conducted in several databases, including PubMed, Web of Science, Cochrane, ClinicalTrials.gov, and Embase, concluding on January 21, 2024, to identify studies that met the inclusion criteria. Twelve studies were included after a rigorous selection process based on predefined criteria. Statistical analyses were conducted using R version 4.0.5 software with the netmeta and dmetar packages, utilizing a frequentist approach with a random-effects model. A network meta-analysis was performed to compare different fat graft procedures with regard to fat survival rate and complication events.</p><p><strong>Results: </strong>CAL and PRP-assisted lipotransfer were better than traditional fat grafting in terms of fat survival rate. In addition, there was no significant difference in the incidence of postoperative complications among the CAL, PRP, and traditional groups.</p><p><strong>Conclusions: </strong>Given the results of network meta-analysis, it appears that both CAL and PRP-assisted lipotransfer have a higher fat survival rate for autologous fat grafting in breast augmentation and reconstruction. However, the transplantation strategy still needs to be analyzed based on actual conditions in clinical applications.</p>","PeriodicalId":20128,"journal":{"name":"Plastic and reconstructive surgery","volume":"155 2","pages":"243e-255e"},"PeriodicalIF":3.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143060156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reliability and Safety of the Superthin Anterolateral Thigh Flap: Evaluating Perfusion-Related Complications and Donor Morbidity. 超薄 ALT 皮瓣的可靠性和安全性:灌注相关并发症和供体发病率的综合评估
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-05-06 DOI: 10.1097/PRS.0000000000011513
Kyung-Eun Yoo, Da Eun Kim, Kyeong-Tae Lee

Background: With an increasing need for thin flaps, the use of superthin anterolateral thigh (ALT) flaps, raised above the supra-superficial fascia, has drawn great attention. Controversy remains regarding whether such thin-flap elevation could affect postoperative outcomes, encompassing perfusion-related complications (PRCs) and donor-site morbidity. This study aimed to evaluate the outcomes of superthin ALT flap-based reconstruction compared with those of suprafascially elevated flaps.

Methods: Patients who underwent free ALT flap-based reconstruction between March of 2017 and June of 2023 were reviewed and categorized into 2 groups based on flap elevation plane: superthin or suprafascial. Development of PRC and donor-site morbidity, including paresthesia, was compared. Independent associations of the elevation plane with complication profiles were evaluated. Further analyses were conducted using propensity score matching.

Results: In total, 208 cases were analyzed: 80 superthin and 128 suprafascial ALT flaps. Nineteen cases (9.1%) experienced PRC, including 4 total and 14 partial necrosis. The incidence of overall and each type of PRC did not differ based on flap elevation plane even after adjusting for other variables. The superthin group exhibited significantly lower donor-site complications compared with the others, which was upheld in multivariable analyses. Elevating the flaps in a superthin fashion allowed for a higher rate of preservation of the lateral femoral cutaneous nerve, resulting in a significantly lower rate of postoperative paresthesia. Similar associations were observed in the propensity score matching analysis.

Conclusion: Superthin ALT flap elevation does not appear to increase PRC risk and reduces donor-site complications, compared with suprafascial elevation.

Clinical question/level of evidence: Therapeutic, IV.

背景:随着对薄皮瓣的需求不断增加,使用高于浅上筋膜的超薄大腿前外侧(ALT)皮瓣引起了广泛关注。关于超薄皮瓣是否会影响术后效果,包括灌注相关并发症(PRC)和供体发病率,目前仍存在争议。本研究旨在评估超薄ALT皮瓣重建与筋膜上隆起皮瓣重建的疗效比较:方法:对2017年3月至2023年6月期间接受游离ALT皮瓣重建的患者进行回顾性研究,并根据皮瓣隆起平面分为超薄和筋膜上两组。比较了PRC的发生情况和供体的发病情况,包括麻痹。评估了隆起平面与并发症情况的独立关联。使用倾向分数匹配法进行了进一步分析:共分析了208个病例:80个超薄ALT皮瓣和128个筋膜上ALT皮瓣。19个病例(9.1%)发生了PRC,包括4个完全坏死和14个部分坏死。即使在调整了其他变量后,皮瓣隆起平面不同,总体和各类 PRC 的发生率也没有差异。超薄组的供体并发症明显低于其他组,这一点在多变量分析中得到了证实。以超薄方式隆起皮瓣可以保留更多的股外侧皮神经,从而显著降低了术后麻痹的发生率。在倾向分数匹配分析中也观察到了类似的关联:超薄 ALT 皮瓣隆起与筋膜上隆起相比,似乎不会增加 PRC 风险,同时减少了供体并发症。
{"title":"Reliability and Safety of the Superthin Anterolateral Thigh Flap: Evaluating Perfusion-Related Complications and Donor Morbidity.","authors":"Kyung-Eun Yoo, Da Eun Kim, Kyeong-Tae Lee","doi":"10.1097/PRS.0000000000011513","DOIUrl":"10.1097/PRS.0000000000011513","url":null,"abstract":"<p><strong>Background: </strong>With an increasing need for thin flaps, the use of superthin anterolateral thigh (ALT) flaps, raised above the supra-superficial fascia, has drawn great attention. Controversy remains regarding whether such thin-flap elevation could affect postoperative outcomes, encompassing perfusion-related complications (PRCs) and donor-site morbidity. This study aimed to evaluate the outcomes of superthin ALT flap-based reconstruction compared with those of suprafascially elevated flaps.</p><p><strong>Methods: </strong>Patients who underwent free ALT flap-based reconstruction between March of 2017 and June of 2023 were reviewed and categorized into 2 groups based on flap elevation plane: superthin or suprafascial. Development of PRC and donor-site morbidity, including paresthesia, was compared. Independent associations of the elevation plane with complication profiles were evaluated. Further analyses were conducted using propensity score matching.</p><p><strong>Results: </strong>In total, 208 cases were analyzed: 80 superthin and 128 suprafascial ALT flaps. Nineteen cases (9.1%) experienced PRC, including 4 total and 14 partial necrosis. The incidence of overall and each type of PRC did not differ based on flap elevation plane even after adjusting for other variables. The superthin group exhibited significantly lower donor-site complications compared with the others, which was upheld in multivariable analyses. Elevating the flaps in a superthin fashion allowed for a higher rate of preservation of the lateral femoral cutaneous nerve, resulting in a significantly lower rate of postoperative paresthesia. Similar associations were observed in the propensity score matching analysis.</p><p><strong>Conclusion: </strong>Superthin ALT flap elevation does not appear to increase PRC risk and reduces donor-site complications, compared with suprafascial elevation.</p><p><strong>Clinical question/level of evidence: </strong>Therapeutic, IV.</p>","PeriodicalId":20128,"journal":{"name":"Plastic and reconstructive surgery","volume":" ","pages":"375-387"},"PeriodicalIF":3.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140891604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Finding Perforator "Freeway" for Design Optimization of Expanded Flaps by Indocyanine Green Angiography. 通过吲哚青绿血管造影术寻找打孔器 "自由通道",优化扩张皮瓣的设计。
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-05-20 DOI: 10.1097/PRS.0000000000011545
Tingjun Xie, Yuanbo Liu, Shan Zhu, Shanshan Li, Zixiang Chen, Tinglu Han, Shengyang Jin, Miao Wang, Mengqing Zang

Summary: Indocyanine green angiography (ICGA) is a useful tool for the visual assessment of superficial blood flow. The authors used ICGA to visualize perforator branches and linking vessels to provide a road map for flap design of an expanded flap. Twenty-eight expansions were planned to use the back-cut technique in 26 patients. ICGA was used to visualize the perforator branching pattern with the linking vessels and the venous network in the expanded flap before expander explantation. The appropriate perforator was selected, and the flap was designed following the axiality of its branch linked by true anastomoses. The vein running closely was chosen as the axial vein. The back cut was designed to avoid transection of the axial artery and vein. Patient characteristics, defect characteristics, and reconstructive outcomes were assessed. ICGA clearly visualized the perforator branches and the linking vessels in the expanded flap at 4the head and neck, trunk, and extremity. The back-cut flap containing the axial artery and vein was raised successfully in 27 expansions. The arterial perforator and superficial vein separated greatly and resulted in design modification from back-cut to advancement flap in one expansion. All expanded flaps met the reconstructive needs and exhibited complete survival. ICGA allowed the visualization of the preoperative topography of the vascular network in the expanded flap and helped surgeons locate the vascular axis and perform an appropriate back-cut design for efficient and safe flap transfer.

Clinical question/level of evidence: Therapeutic, IV.

摘要:吲哚菁绿血管造影术(ICGA)是直观评估浅表血流的有用工具。在此,我们使用 ICGA 观察穿孔器分支和连接血管,为扩张皮瓣的皮瓣设计提供路线图。我们计划对 26 名患者采用后切技术进行 28 次扩张。在剥离扩张器之前,使用 ICGA 观察扩张皮瓣中穿孔器分支模式、连接血管和静脉网络。选择合适的穿孔器,并根据其通过真正吻合连接的分支的轴向设计皮瓣。选择紧邻的静脉作为轴向静脉。背部切口的设计可避免横切轴动静脉。对患者的人口统计学特征、缺损特征和重建结果进行了评估。在头颈部、躯干和四肢的扩张皮瓣中,ICGA能清晰地观察到穿孔器分支和连接血管。在 27 例扩张术中,包含轴动脉和静脉的后切皮瓣成功隆起。动脉穿孔器和浅静脉分离严重,导致在一次扩张中从背切皮瓣设计修改为推进皮瓣。所有扩张的皮瓣都满足了重建需求,并完全存活。ICGA 使扩大皮瓣中血管网络的术前地形可视化,帮助外科医生定位血管轴,并进行适当的背切设计,以实现高效、安全的皮瓣转移。
{"title":"Finding Perforator \"Freeway\" for Design Optimization of Expanded Flaps by Indocyanine Green Angiography.","authors":"Tingjun Xie, Yuanbo Liu, Shan Zhu, Shanshan Li, Zixiang Chen, Tinglu Han, Shengyang Jin, Miao Wang, Mengqing Zang","doi":"10.1097/PRS.0000000000011545","DOIUrl":"10.1097/PRS.0000000000011545","url":null,"abstract":"<p><strong>Summary: </strong>Indocyanine green angiography (ICGA) is a useful tool for the visual assessment of superficial blood flow. The authors used ICGA to visualize perforator branches and linking vessels to provide a road map for flap design of an expanded flap. Twenty-eight expansions were planned to use the back-cut technique in 26 patients. ICGA was used to visualize the perforator branching pattern with the linking vessels and the venous network in the expanded flap before expander explantation. The appropriate perforator was selected, and the flap was designed following the axiality of its branch linked by true anastomoses. The vein running closely was chosen as the axial vein. The back cut was designed to avoid transection of the axial artery and vein. Patient characteristics, defect characteristics, and reconstructive outcomes were assessed. ICGA clearly visualized the perforator branches and the linking vessels in the expanded flap at 4the head and neck, trunk, and extremity. The back-cut flap containing the axial artery and vein was raised successfully in 27 expansions. The arterial perforator and superficial vein separated greatly and resulted in design modification from back-cut to advancement flap in one expansion. All expanded flaps met the reconstructive needs and exhibited complete survival. ICGA allowed the visualization of the preoperative topography of the vascular network in the expanded flap and helped surgeons locate the vascular axis and perform an appropriate back-cut design for efficient and safe flap transfer.</p><p><strong>Clinical question/level of evidence: </strong>Therapeutic, IV.</p>","PeriodicalId":20128,"journal":{"name":"Plastic and reconstructive surgery","volume":" ","pages":"414e-418e"},"PeriodicalIF":3.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141082088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proximal Interphalangeal Joint Arthroplasty for Osteoarthritis: A Long-Term Follow-Up. "治疗骨关节炎的近端指间关节置换术:患者满意度、密歇根手部结果问卷评分和再手术的长期随访"。
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-06-24 DOI: 10.1097/PRS.0000000000011599
Bo J W Notermans, Joris S Teunissen, Lisa Hoogendam, Luitzen H L de Boer, Ruud W Selles, Brigitte E P A van der Heijden

Background: Previously published research describes short-term outcomes after proximal interphalangeal (PIP) joint arthroplasty; however, long-term outcomes are scarce. Therefore, the authors evaluated patient-reported outcomes and complications after a follow-up of at least 5 years following PIP joint arthroplasty.

Methods: The authors used prospectively gathered data from patients undergoing PIP joint arthroplasty with silicone or surface replacement implants. Time points included preoperatively, 1 year postoperatively, and at least 5 years postoperatively. The authors were able to include 74 patients. Primarily, the authors focused on patient satisfaction with the treatment outcome, measured using a validated 5-point Likert scale. Secondary outcomes included the questions of whether patients would undergo the same surgery again, the assessment of factors associated with satisfaction or dissatisfaction, the Michigan Hand Outcomes Questionnaire score, and the number of reoperations.

Results: The mean follow-up was 7 ± 1.2 years (range, 5 to 11 years). Patient satisfaction was excellent in 14 patients (19%), good in 17 patients (23%), reasonable in 18 patients (24%), moderate in 10 patients (14%), and poor in 15 patients (20%). Seventy-three percent of patients ( n = 54) would undergo the same procedure again. The authors found no factors associated with satisfaction or dissatisfaction. All Michigan Hand Outcomes Questionnaire scores improved significantly in the first year after surgery and did not deteriorate afterward. Sixteen fingers (16%) required a reoperation, of which 3 (4%) needed a prosthesis replacement.

Conclusions: Patient satisfaction with treatment outcomes 7 years after PIP implant surgery ranges from moderate to good for many patients, with a notable proportion expressing dissatisfaction. Patient-reported outcomes improve primarily within the first year and remain stable at 5 years or more.

Clinical question/level of evidence: Therapeutic, IV.

背景:以前发表的研究描述了近端指间关节(PIP)关节置换术后的短期疗效,但长期疗效却很少见。因此,我们对 PIP 关节置换术后至少五年的随访结果和并发症进行了评估:我们采用了前瞻性收集的数据,这些数据来自接受 PIP 关节置换术并植入硅胶或表面置换假体的患者。时间点包括术前、术后一年和至少五年。我们共纳入了 74 名患者。我们主要关注患者对治疗结果的满意度,采用经过验证的 5 点李克特量表进行测量。次要结果包括患者是否会再次接受同样的手术、与(不)满意度相关的因素评估、密歇根手部结果问卷(MHQ)以及再次手术的次数:平均随访时间为 7 年(SD 1.2,范围为 5-11 年)。14例(19%)患者的满意度为优,17例(23%)患者的满意度为良,18例(24%)患者的满意度为良,10例(14%)患者的满意度为中,15例(20%)患者的满意度为差。73%的患者(54 人)愿意再次接受同样的手术。我们没有发现与(不)满意度相关的因素。所有 MHQ 评分在术后第一年都有明显改善,之后也没有恶化。16例(16%)手指需要再次手术,其中3例(4%)需要更换假体:结论:许多患者对PIP植入手术七年后的治疗效果的满意度从中等到良好不等,但也有相当一部分患者表示不满意。患者报告的结果主要在第一年内得到改善,并在五年或更长时间内保持稳定:证据等级:II。
{"title":"Proximal Interphalangeal Joint Arthroplasty for Osteoarthritis: A Long-Term Follow-Up.","authors":"Bo J W Notermans, Joris S Teunissen, Lisa Hoogendam, Luitzen H L de Boer, Ruud W Selles, Brigitte E P A van der Heijden","doi":"10.1097/PRS.0000000000011599","DOIUrl":"10.1097/PRS.0000000000011599","url":null,"abstract":"<p><strong>Background: </strong>Previously published research describes short-term outcomes after proximal interphalangeal (PIP) joint arthroplasty; however, long-term outcomes are scarce. Therefore, the authors evaluated patient-reported outcomes and complications after a follow-up of at least 5 years following PIP joint arthroplasty.</p><p><strong>Methods: </strong>The authors used prospectively gathered data from patients undergoing PIP joint arthroplasty with silicone or surface replacement implants. Time points included preoperatively, 1 year postoperatively, and at least 5 years postoperatively. The authors were able to include 74 patients. Primarily, the authors focused on patient satisfaction with the treatment outcome, measured using a validated 5-point Likert scale. Secondary outcomes included the questions of whether patients would undergo the same surgery again, the assessment of factors associated with satisfaction or dissatisfaction, the Michigan Hand Outcomes Questionnaire score, and the number of reoperations.</p><p><strong>Results: </strong>The mean follow-up was 7 ± 1.2 years (range, 5 to 11 years). Patient satisfaction was excellent in 14 patients (19%), good in 17 patients (23%), reasonable in 18 patients (24%), moderate in 10 patients (14%), and poor in 15 patients (20%). Seventy-three percent of patients ( n = 54) would undergo the same procedure again. The authors found no factors associated with satisfaction or dissatisfaction. All Michigan Hand Outcomes Questionnaire scores improved significantly in the first year after surgery and did not deteriorate afterward. Sixteen fingers (16%) required a reoperation, of which 3 (4%) needed a prosthesis replacement.</p><p><strong>Conclusions: </strong>Patient satisfaction with treatment outcomes 7 years after PIP implant surgery ranges from moderate to good for many patients, with a notable proportion expressing dissatisfaction. Patient-reported outcomes improve primarily within the first year and remain stable at 5 years or more.</p><p><strong>Clinical question/level of evidence: </strong>Therapeutic, IV.</p>","PeriodicalId":20128,"journal":{"name":"Plastic and reconstructive surgery","volume":" ","pages":"334e-342e"},"PeriodicalIF":3.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141458700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High Above-Knee Amputations for Femoral Osteosarcomas Treated with Free Microsurgical Tibial Reconstruction in the Pediatric Population. 用游离显微外科胫骨重建术治疗小儿股骨肉瘤的膝上高位截肢术
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-07-19 DOI: 10.1097/PRS.0000000000011646
Courtney G Wilkes, Andrew H Huang, David B McCombe, Christopher J Coombs

Summary: Improvements in the management of pediatric sarcoma, including imaging, neo- and adjuvant therapy, and surgical technique, have enhanced long-term survival. Pediatric patients diagnosed with a femoral osteosarcoma undergoing oncologic resection who are ineligible for limb-preservation reconstruction or rotationplasty are offered an above-knee amputation (AKA). Limb amputation in the skeletally immature patient poses particular problems specific to endosteal bone overgrowth and spiking. Approximately half of these patients undergo revision of their amputation site. Furthermore, a high AKA often requires a hip-based prosthesis, which can be uncomfortable, leading to poorer outcomes and higher energy expenditures. The authors have completed 4 "spare parts" microvascular free tibial transfers for pediatric patients diagnosed with femoral osteosarcoma who were treated with an AKA. Two of these patients are ambulatory with their prosthesis and have not required long-term revision of their amputation site. One patient demonstrated radiographic evidence of bony union 4 months postoperatively, but subsequently died of chemotherapy-resistant metastases. The fourth patient is in the process of prosthetic fitting and rehabilitation. This is a novel technique, and the authors present the first series describing both proximal and distal free microvascular tibial bone transfers as a reconstructive option for pediatric patients with femoral osteosarcomas. This reliable flap, which has possible variations in vascular anatomy, offers multiple benefits, including prevention of bony spiking, AKA stump augmentation, and facilitation of appropriate prosthetic fitting, improving functional outcomes and leading to decreased energy expenditure. The soft-tissue coverage must be well-planned.

摘要:儿科肉瘤治疗方法的改进,包括影像学、新辅助和辅助治疗以及手术技术,提高了患者的长期生存率。被诊断为股骨肉瘤的小儿患者在接受肿瘤切除术时,如果不符合保肢重建或旋转成形术的条件,就会接受膝上截肢术(AKA)。骨骼尚未发育成熟的患者截肢会面临骨内膜骨过度生长和骨刺的特殊问题。这些患者中约有一半需要对截肢部位进行翻修。此外,高AKA通常需要使用髋关节假体,这可能会让患者感到不舒服,从而导致较差的治疗效果和较高的能量消耗。我们已经完成了四例 "备件 "微血管游离胫骨转移术,用于治疗被诊断为股骨肉瘤并接受AKA治疗的儿童患者。其中两名患者目前可以使用假肢行走,并且不需要对截肢部位进行长期翻修。一名患者在术后四个月出现骨结合的影像学证据,但随后因化疗耐药转移而死亡。这是一项新颖的技术,也是首个将游离胫骨近端和远端微血管骨移植作为股骨肉瘤儿童患者重建选择的系列报道。这是一种可靠的皮瓣,但血管解剖可能会有变化。此外,它还具有多种益处,包括防止骨刺(又称残端增高)、便于安装合适的假体、改善功能效果和减少能量消耗。不过,必须对软组织覆盖进行周密的规划。
{"title":"High Above-Knee Amputations for Femoral Osteosarcomas Treated with Free Microsurgical Tibial Reconstruction in the Pediatric Population.","authors":"Courtney G Wilkes, Andrew H Huang, David B McCombe, Christopher J Coombs","doi":"10.1097/PRS.0000000000011646","DOIUrl":"10.1097/PRS.0000000000011646","url":null,"abstract":"<p><strong>Summary: </strong>Improvements in the management of pediatric sarcoma, including imaging, neo- and adjuvant therapy, and surgical technique, have enhanced long-term survival. Pediatric patients diagnosed with a femoral osteosarcoma undergoing oncologic resection who are ineligible for limb-preservation reconstruction or rotationplasty are offered an above-knee amputation (AKA). Limb amputation in the skeletally immature patient poses particular problems specific to endosteal bone overgrowth and spiking. Approximately half of these patients undergo revision of their amputation site. Furthermore, a high AKA often requires a hip-based prosthesis, which can be uncomfortable, leading to poorer outcomes and higher energy expenditures. The authors have completed 4 \"spare parts\" microvascular free tibial transfers for pediatric patients diagnosed with femoral osteosarcoma who were treated with an AKA. Two of these patients are ambulatory with their prosthesis and have not required long-term revision of their amputation site. One patient demonstrated radiographic evidence of bony union 4 months postoperatively, but subsequently died of chemotherapy-resistant metastases. The fourth patient is in the process of prosthetic fitting and rehabilitation. This is a novel technique, and the authors present the first series describing both proximal and distal free microvascular tibial bone transfers as a reconstructive option for pediatric patients with femoral osteosarcomas. This reliable flap, which has possible variations in vascular anatomy, offers multiple benefits, including prevention of bony spiking, AKA stump augmentation, and facilitation of appropriate prosthetic fitting, improving functional outcomes and leading to decreased energy expenditure. The soft-tissue coverage must be well-planned.</p>","PeriodicalId":20128,"journal":{"name":"Plastic and reconstructive surgery","volume":" ","pages":"428e-432e"},"PeriodicalIF":3.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141724166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robotic Nipple Sparing Mastectomy and Breast Reconstruction with Profunda Artery Perforator Flaps.
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2025-01-28 DOI: 10.1097/PRS.0000000000011999
Nicholas T Haddock, Sumeet S Teotia, Deborah Farr

Summary: The single port robotic nipple sparing mastectomy (SPrNSM) was recently introduced. This approach is safe and has led to favorable outcomes in relation to cosmetic result, patient satisfaction, and breast sensation. The typical reconstruction with all robotic nipple sparing mastectomies is implant based; however, this is not always what a patient desires. We present autologous tissue reconstruction with PAP flaps following SPrNSM using the same axillary incision. A retrospective review of all patients treated with a PAP flap for breast reconstruction and SPrNSM at our institution from July 2022 to May 2023 was performed. Six patients underwent SPrNSM with PAP flap breast reconstruction (three delayed immediate and three immediate reconstruction). Three patients underwent subsequent revision with fat grafting. Breast reconstruction following robotic nipple sparing mastectomy has typically been performed with implants. We present a series of patients treated with PAP flaps for autologous reconstruction utilizing the same remote axillary incision as used in SPrNSM.

{"title":"Robotic Nipple Sparing Mastectomy and Breast Reconstruction with Profunda Artery Perforator Flaps.","authors":"Nicholas T Haddock, Sumeet S Teotia, Deborah Farr","doi":"10.1097/PRS.0000000000011999","DOIUrl":"https://doi.org/10.1097/PRS.0000000000011999","url":null,"abstract":"<p><strong>Summary: </strong>The single port robotic nipple sparing mastectomy (SPrNSM) was recently introduced. This approach is safe and has led to favorable outcomes in relation to cosmetic result, patient satisfaction, and breast sensation. The typical reconstruction with all robotic nipple sparing mastectomies is implant based; however, this is not always what a patient desires. We present autologous tissue reconstruction with PAP flaps following SPrNSM using the same axillary incision. A retrospective review of all patients treated with a PAP flap for breast reconstruction and SPrNSM at our institution from July 2022 to May 2023 was performed. Six patients underwent SPrNSM with PAP flap breast reconstruction (three delayed immediate and three immediate reconstruction). Three patients underwent subsequent revision with fat grafting. Breast reconstruction following robotic nipple sparing mastectomy has typically been performed with implants. We present a series of patients treated with PAP flaps for autologous reconstruction utilizing the same remote axillary incision as used in SPrNSM.</p>","PeriodicalId":20128,"journal":{"name":"Plastic and reconstructive surgery","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143060129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of omega-3 polyunsaturated fatty acids on inflammation resolution and angiogenesis in fat grafts in a controlled mouse model.
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2025-01-28 DOI: 10.1097/PRS.0000000000011997
Ming Li, Facheng Li

Background: The upregulation or delay of acute inflammation at any stage limits fat graft survival. Active endogenous inflammation resolution mechanisms and mediators are novel therapeutic tools for inflammation. This study explored the effects of supplementation of omega-3 polyunsaturated fatty acids (PUFAs) deriving specialized proresolving mediators (SPMs) on postoperative inflammation and graft survival in vivo.

Methods: Fish oil (FO) (or saline for the control group) was intragastrically administered in the C57BL/6N mouse fat graft model for a week before and after transplantation. The mice were euthanized at 3, 7, 14, 30, or 90 days posttransplantation. Serum C-reactive protein (CRP) concentration was determined via enzyme-linked immunosorbent assay (ELISA); gene expression levels of inflammatory factors, perilipin-1 and vascular endothelial growth factor (VEGF) in the grafts were analyzed via quantitative real-time PCR (QPCR); hematoxylin and eosin (H&E), masson's trichrome, immunohistochemistry (IHC) and immunofluorescence (IF) staining were performed.

Results: Omega-3 PUFAs reduced the serum CRP concentration. Additionally, in the grafts of FO group, proinflammatory factors expression was reduced while anti-inflammatory factors expression was increased; the CD11b+ IF intensity at Days 14 and 30 was reduced, the F4/80+/CD11b+ ratio at Days 3 and 7 and the CD206+/F4/80+ ratio at Days 7, 14, and 30 were increased, consistent with the results of IHC control staining (CD11b, F4/80 and CD206); the gene expression of VEGF at Day 14 and perilipin-1 at Days 30 and 90 were increased; the perilipin-1+ %area and CD31+ %area at Day 90 were increased; inflammatory cell infiltration and fibrosis were decreased.

Conclusion: Omega-3 PUFAs can enhance inflammation resolution and angiogenesis and promotes fat graft survival in a controlled mouse model.

{"title":"Effects of omega-3 polyunsaturated fatty acids on inflammation resolution and angiogenesis in fat grafts in a controlled mouse model.","authors":"Ming Li, Facheng Li","doi":"10.1097/PRS.0000000000011997","DOIUrl":"https://doi.org/10.1097/PRS.0000000000011997","url":null,"abstract":"<p><strong>Background: </strong>The upregulation or delay of acute inflammation at any stage limits fat graft survival. Active endogenous inflammation resolution mechanisms and mediators are novel therapeutic tools for inflammation. This study explored the effects of supplementation of omega-3 polyunsaturated fatty acids (PUFAs) deriving specialized proresolving mediators (SPMs) on postoperative inflammation and graft survival in vivo.</p><p><strong>Methods: </strong>Fish oil (FO) (or saline for the control group) was intragastrically administered in the C57BL/6N mouse fat graft model for a week before and after transplantation. The mice were euthanized at 3, 7, 14, 30, or 90 days posttransplantation. Serum C-reactive protein (CRP) concentration was determined via enzyme-linked immunosorbent assay (ELISA); gene expression levels of inflammatory factors, perilipin-1 and vascular endothelial growth factor (VEGF) in the grafts were analyzed via quantitative real-time PCR (QPCR); hematoxylin and eosin (H&E), masson's trichrome, immunohistochemistry (IHC) and immunofluorescence (IF) staining were performed.</p><p><strong>Results: </strong>Omega-3 PUFAs reduced the serum CRP concentration. Additionally, in the grafts of FO group, proinflammatory factors expression was reduced while anti-inflammatory factors expression was increased; the CD11b+ IF intensity at Days 14 and 30 was reduced, the F4/80+/CD11b+ ratio at Days 3 and 7 and the CD206+/F4/80+ ratio at Days 7, 14, and 30 were increased, consistent with the results of IHC control staining (CD11b, F4/80 and CD206); the gene expression of VEGF at Day 14 and perilipin-1 at Days 30 and 90 were increased; the perilipin-1+ %area and CD31+ %area at Day 90 were increased; inflammatory cell infiltration and fibrosis were decreased.</p><p><strong>Conclusion: </strong>Omega-3 PUFAs can enhance inflammation resolution and angiogenesis and promotes fat graft survival in a controlled mouse model.</p>","PeriodicalId":20128,"journal":{"name":"Plastic and reconstructive surgery","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143060126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound-Guided Maxillary Nerve Block in Nasal Surgery.
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2025-01-28 DOI: 10.1097/PRS.0000000000011996
Cindy Vu, Sierra Hewett Willens, Leonardo Alaniz, Ja'Neil G Humphrey, Nikhil Shah, Raj M Vyas, Miles J Pfaff

Summary / unstructured abstract: Emphasis on enhanced recovery after surgery (ERAS) protocols and opioid use reduction have led to a growing interest in alternative pain management strategies. This study describes and evaluates the ultrasound-guided suprazygomatic maxillary (SZM) nerve blocks for patients undergoing functional and cosmetic nasal surgery as an adjunct to postoperative pain management. A retrospective, multicenter analysis was conducted on patients who underwent functional nasal surgery and rhinoplasty and evaluated the impact of SZM blocks on intraoperative anesthetic and opioid use, postoperative pain scores recorded in the PACU, and PACU length. A total of 64 patients met inclusion criteria. Twenty-five patients received a SZM block prior to undergoing the procedure while the remaining patients underwent standard local anesthetic use. SZM blocks significantly reduced the amount of intraoperative pain medication used (p = 0.02), including hydromorphone (p=0.007), when compared to a traditional approach to local anesthetic use. SZM blocks also significantly reduced post-anesthesia PACU stay at one institution (p=0.016). SZM nerve blocks are a simple and effective way to deliver local anesthetic and are associated with decreased intraoperative opioid use and PACU stay.

{"title":"Ultrasound-Guided Maxillary Nerve Block in Nasal Surgery.","authors":"Cindy Vu, Sierra Hewett Willens, Leonardo Alaniz, Ja'Neil G Humphrey, Nikhil Shah, Raj M Vyas, Miles J Pfaff","doi":"10.1097/PRS.0000000000011996","DOIUrl":"https://doi.org/10.1097/PRS.0000000000011996","url":null,"abstract":"<p><strong>Summary / unstructured abstract: </strong>Emphasis on enhanced recovery after surgery (ERAS) protocols and opioid use reduction have led to a growing interest in alternative pain management strategies. This study describes and evaluates the ultrasound-guided suprazygomatic maxillary (SZM) nerve blocks for patients undergoing functional and cosmetic nasal surgery as an adjunct to postoperative pain management. A retrospective, multicenter analysis was conducted on patients who underwent functional nasal surgery and rhinoplasty and evaluated the impact of SZM blocks on intraoperative anesthetic and opioid use, postoperative pain scores recorded in the PACU, and PACU length. A total of 64 patients met inclusion criteria. Twenty-five patients received a SZM block prior to undergoing the procedure while the remaining patients underwent standard local anesthetic use. SZM blocks significantly reduced the amount of intraoperative pain medication used (p = 0.02), including hydromorphone (p=0.007), when compared to a traditional approach to local anesthetic use. SZM blocks also significantly reduced post-anesthesia PACU stay at one institution (p=0.016). SZM nerve blocks are a simple and effective way to deliver local anesthetic and are associated with decreased intraoperative opioid use and PACU stay.</p>","PeriodicalId":20128,"journal":{"name":"Plastic and reconstructive surgery","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143060134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Plastic and reconstructive surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1